Saltar al contenido

aptericia

@aptericia.bsky.social did:plc:2w7i4kic7xd6wuko7cxosf6y

USA, English-speaking, she/her, 21 y.o. Expect Fire Emblem, Octopath Traveler, Thunderbolt Fantasy, Revolutionary Girl Utena, and birbs. I draw fanart sometimes! ‼️BLM | Land Back | trans rights are human rights‼️

En Bluesky desde el

Seguidores
192
Siguiendo
241
Posts
1.239
Días en rankings
0

Resumen

aptericia (@aptericia.bsky.social) es un usuario de Bluesky que se unió el 29 noviembre 2023. Tiene 192 seguidores, sigue a 241 cuentas y ha publicado 1.239 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • var 🍮@sevarix.bsky.social

    check out the artist! www.tumblr.com/dandywontshu...

    Ver post
  • var 🍮@sevarix.bsky.social

    i got some beautiful art from dandywontshutup on tumblr! 🥰 tysm!!!!!!

    Ver post
  • Crow 🌿@crowlines.net

    Thanks for the love on the new pigeon shirt! It was the most popular shirt in last month's update 🎉 I'm sold out of XS and fairly low on size S too as a heads up! crowlines.net

    Ver post
  • the gay spectre (🏳️‍🌈☭)@orbitalis.bsky.social

    for the American voters: IGNORE THE POLLS! this is literally what we did in Brazil! it doesn't matter if your party is ahead or behind, GO VOTE! some people give up on voting because they're sure they'll win or lose and their vote doesn't matter AND THAT'S WHEN YOU LOSE! WAKE UP EARLY AND VOTE!

    Ver post
  • Chise@sailorrooscout.bsky.social

    GOOD NEWS! A personalized mRNA vaccine, known as mRNA-1457, has SUCCEEDED in keeping melanoma, a deadly skin cancer, from returning. Phase III clinical trial results in MORE THAN 1,100 patients shows the vaccine SIGNIFICANTLY cut the risk of death OR recurrence of melanoma by ALMOST HALF.

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.